Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32

Benzinga Newsdesk www.benzinga.com Neutral 55.9%

Neg 0% Neu 55.9% Pos 0%

Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ:SMTI) with a Buy rating and announces Price Target of $32.